chrX-67546514-TGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGC-T

Variant summary

Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BS2

The NM_000044.6(AR):​c.1388_1420delGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCG​(p.Gly463_Gly473del) variant causes a disruptive inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000588 in 559,143 control chromosomes in the GnomAD database, including 37 homozygotes. There are 92 hemizygotes in GnomAD. It is difficult to determine the true allele frequency of this variant because it is of type DEL_BIG, and the frequency of such variant types in population databases may be underestimated and unreliable. Variant has been reported in ClinVar as Uncertain significance (★). Synonymous variant affecting the same amino acid position (i.e. G463G) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00076 ( 1 hom., 14 hem., cov: 0)
Exomes 𝑓: 0.00056 ( 36 hom. 78 hem. )

Consequence

AR
NM_000044.6 disruptive_inframe_deletion

Scores

Not classified

Clinical Significance

Uncertain significance criteria provided, single submitter U:1B:1

Conservation

PhyloP100: 1.29

Publications

6 publications found
Variant links:
Genes affected
AR (HGNC:644): (androgen receptor) The androgen receptor gene is more than 90 kb long and codes for a protein that has 3 major functional domains: the N-terminal domain, DNA-binding domain, and androgen-binding domain. The protein functions as a steroid-hormone activated transcription factor. Upon binding the hormone ligand, the receptor dissociates from accessory proteins, translocates into the nucleus, dimerizes, and then stimulates transcription of androgen responsive genes. This gene contains 2 polymorphic trinucleotide repeat segments that encode polyglutamine and polyglycine tracts in the N-terminal transactivation domain of its protein. Expansion of the polyglutamine tract from the normal 9-34 repeats to the pathogenic 38-62 repeats causes spinal bulbar muscular atrophy (SBMA, also known as Kennedy's disease). Mutations in this gene are also associated with complete androgen insensitivity (CAIS). Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jan 2017]
AR Gene-Disease associations (from GenCC):
  • androgen insensitivity syndrome
    Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine
  • Kennedy disease
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen, G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • partial androgen insensitivity syndrome
    Inheritance: XL Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp
  • complete androgen insensitivity syndrome
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -4 ACMG points.

BS2
High Hemizygotes in GnomAd4 at 14 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ARNM_000044.6 linkc.1388_1420delGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCG p.Gly463_Gly473del disruptive_inframe_deletion Exon 1 of 8 ENST00000374690.9 NP_000035.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ARENST00000374690.9 linkc.1388_1420delGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCG p.Gly463_Gly473del disruptive_inframe_deletion Exon 1 of 8 1 NM_000044.6 ENSP00000363822.3 P10275-1

Frequencies

GnomAD3 genomes
AF:
0.000746
AC:
62
AN:
83056
Hom.:
1
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.00129
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00218
Gnomad ASJ
AF:
0.000900
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00131
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000278
Gnomad OTH
AF:
0.000943
GnomAD4 exome
AF:
0.000559
AC:
266
AN:
476083
Hom.:
36
AF XY:
0.000660
AC XY:
78
AN XY:
118139
show subpopulations
African (AFR)
AF:
0.00250
AC:
33
AN:
13215
American (AMR)
AF:
0.00303
AC:
26
AN:
8582
Ashkenazi Jewish (ASJ)
AF:
0.00136
AC:
13
AN:
9541
East Asian (EAS)
AF:
0.000355
AC:
5
AN:
14084
South Asian (SAS)
AF:
0.00102
AC:
15
AN:
14715
European-Finnish (FIN)
AF:
0.0000915
AC:
2
AN:
21851
Middle Eastern (MID)
AF:
0.00613
AC:
8
AN:
1306
European-Non Finnish (NFE)
AF:
0.000347
AC:
129
AN:
372195
Other (OTH)
AF:
0.00170
AC:
35
AN:
20594
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.683
Heterozygous variant carriers
0
4
8
12
16
20
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000758
AC:
63
AN:
83060
Hom.:
1
Cov.:
0
AF XY:
0.000842
AC XY:
14
AN XY:
16630
show subpopulations
African (AFR)
AF:
0.00134
AC:
29
AN:
21654
American (AMR)
AF:
0.00217
AC:
17
AN:
7817
Ashkenazi Jewish (ASJ)
AF:
0.000900
AC:
2
AN:
2222
East Asian (EAS)
AF:
0.00
AC:
0
AN:
2563
South Asian (SAS)
AF:
0.00131
AC:
2
AN:
1522
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
2382
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
174
European-Non Finnish (NFE)
AF:
0.000278
AC:
12
AN:
43137
Other (OTH)
AF:
0.000929
AC:
1
AN:
1076
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.564
Heterozygous variant carriers
0
2
4
7
9
11
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
327

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Androgen resistance syndrome;C1839259:Kennedy disease Uncertain:1
Feb 24, 2021
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. This variant has not been reported in the literature in individuals with AR-related conditions. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate insufficient coverage at this position in the ExAC database. This variant, c.1388_1420del, results in the deletion of 11 amino acid(s) of the AR protein (p.Gly463_Gly473del), but otherwise preserves the integrity of the reading frame. -

AR-related disorder Benign:1
Sep 20, 2021
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
1.3
Mutation Taster
=199/1
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs746853821; hg19: chrX-66766356; COSMIC: COSV65963038; API